Nextleaf Solutions Ltd. (formerly Legion Metals Corp.) (“Nextleaf” or the “Company”) (CSE:OILS) is pleased to announce that it has closed the previously announced reverse takeover transaction (the “Transaction”) with Nextleaf Innovations Ltd. (“Nextleaf Innovations”; formerly Nextleaf Solutions Ltd). As a result of the Transaction, the Company has acquired all of the issued and outstanding shares of Nextleaf Innovations, and Nextleaf Innovations will become the wholly-owned subsidiary of the Company.
The common shares of the Company are expected to resume trading on the Canadian Securities Exchange (the “CSE”) under the new ticker symbol “OILS” as soon as possible subsequent to receiving CSE final approval of the Transaction. The CSE Form 2A Listing Statement (the “Listing Statement”) of the Company in connection with the Transaction (as prepared pursuant to the policies of the CSE) will be filed on SEDAR (www.sedar.com) prior to the resumption of trading.
The Transaction was completed by way of plan of arrangement. Former Nextleaf Innovations shareholders now hold an aggregate of 92,979,101 shares of the Company, representing 96.23% of the issued and outstanding shares, and remaining Legion shareholders hold an aggregate of 3,647,029 shares of the Company, representing 3.77% of the issued and outstanding shares.
Legion’s management and board were replaced by incoming management and board members of Nextleaf Innovations and have resigned in connection with the Transaction. Additional details regarding the Company’s new board and management team can be found in the Listing Statement.
Nextleaf’s Management Team
Paul Pedersen, Chief Executive Officer and Director
Mr. Pedersen has been focused on the cannabis industry since 2013, consulting for a variety of cannabis companies and investors including Canada’s first cannabis oil producer. He has founded several startups over his career, including a media company acquired in 2007 by Towerstream Corporation (NASDAQ: TWER). Paul holds a MBA in Finance from the Eli Broad Graduate School of Management at Michigan State University and a Bachelor of Commerce Degree from the Sobey School of Business at Saint Mary’s University.
Charles Ackerman, Chief Financial Officer and Director
Mr. Ackerman is a Chartered Accountant who has successfully led mergers and acquisitions, divestitures and private and public capital raises. He has served in a number of finance and corporate leadership roles developing and executing growth strategies, with private and public companies and family offices across Canada. Charles previously consulted for Canada’s first new federally licensed commercial medical cannabis producer. He holds a Bachelor of Commerce Degree from the Sobey School of Business at Saint Mary’s University.
Ryan Ko, Chief Technology Officer
Through his extensive career in the legal cannabis industry, Mr. Ko has developed deep expertise and intellectual property within extraction technology, leading to Canada’s first processing patent for cannabis extraction and purification. Mr. Ko leads the development of Nextleaf’s proprietary cannabis processing technology.
In connection with the Transaction, Nextleaf Innovations completed a brokered and a non-brokered private placement (together, the “Private Placements”) of units of Nextleaf Innovations (each, a “Unit”) at a price of $0.35 per Unit for aggregate gross proceeds of $5,000,000. Mackie Research Capital Corporation acted as lead agent and sole bookrunner on the brokered portion of the Private Placements, on behalf of a syndicate of agents including Industrial Alliance Securities Inc. and Gravitas Securities Inc.
Each Unit is comprised of one common share in the capital of Nextleaf Innovations (a “Common Share”) and one common share purchase warrant of Nextleaf Innovations (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of $0.70 at any time up to 24 months following Closing of the Private Placements, provided that if, at any time prior to the expiry date of the Warrants, the closing price of the Common Shares on the CSE or any other stock exchange on which the Common Shares are listed exceeds $1.25 for 20 consecutive trading days, the expiry date of the Warrants shall automatically accelerate and will expire on the date that is 30 days following the date of notice provided to the Warrant holders by way of a press release.
Each of the Units issued pursuant to the Private Placements were automatically exchanged, for no additional consideration, into one Unit of the Company as part of the Transaction.
About Nextleaf Solutions
Nextleaf Solutions Ltd. (CSE: OILS) is an extraction technology company that has developed a portfolio of issued and pending patents pertaining to the company’s unique, industrial-scale process of producing purified cannabinoid distillate, a tasteless, odourless cannabis concentrate best suited for infusing premium value-added products. Nextleaf plans to commercialize its intellectual property portfolio by providing B2B processing services to licensed cultivators and supplying cannabis oil and extracts to qualified Canadian and international partners under the client’s own brands. Nextleaf has completed construction of its dedicated extraction and processing facility in Greater Vancouver, British Columbia, in time for Canada’s legalization of edibles and other cannabis derivative products. The Company’s processing facility includes research and laboratory infrastructure, allowing for the continued development of novel, scalable cannabis processing technology and intellectual property.
ON BEHALF OF THE BOARD OF NEXTLEAF SOLUTIONS LTD.
Paul Pedersen, CEO
This press release contains “forward-looking information” that is based on the Company’s current expectations, estimates, forecasts and projections. This forward-looking information includes, among other things, the Company’s business, plans, outlook and business strategy. The words “may”, “would”, “could”, “should”, “will”, “likely”, “expect,” “anticipate,” “intend”, “estimate”, “plan”, “forecast”, “project” and “believe” or other similar words and phrases are intended to identify forward-looking information. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the contents of this press release.
SOURCE Nextleaf Solutions Ltd.
For further information: For further information on Nextleaf, please refer to the Company’s disclosure record on SEDAR (www.sedar.com) or contact the Company by telephone at 604-283-2301 (ext. 201), email at email@example.com, or visit them online at www.nextleafsolutions.com
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).